Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
Adefovir dipivoxil (ADV) is a nucleotide analogue used in the chronic hepatitis B treatment. Proximal renal tubular dysfunction is one of the adverse effects of this agent and characterized with hypophosphatemia and osteomalacia. However, reduced bone mineral density with fracture due to ADV therapy...
Main Authors: | Sevilay Batıbay, Duygu Geler Külcü, Nilgün Mesci, Borçak Çağlar Ruhi, Zerrin Şahin, Hasan Gündoğdu |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-08-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://cms.galenos.com.tr/Uploads/Article_19913/TOD-24-59-En.pdf |
Similar Items
-
Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series
by: Nan Chen, et al.
Published: (2018-05-01) -
Fanconi syndrome with hypophosphatemic osteomalacia induced by low-dose adefovir dipivoxil
by: WANG Shouqing, et al.
Published: (2016-01-01) -
Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
by: Qian YY, et al.
Published: (2019-04-01) -
Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil
by: Zhu S, et al.
Published: (2017-12-01) -
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report
by: Tomohisa Kunii, et al.
Published: (2019-04-01)